ARTICLE | Clinical News
Cymbalta duloxetine regulatory update
November 8, 2010 8:00 AM UTC
FDA approved an sNDA from Eli Lilly to expand the label of Cymbalta duloxetine to include the treatment of chronic musculoskeletal pain. In August an FDA advisory committee voted 8-5 with one abstenti...